Tedizolid
ATC J01XX11 · 8 markets · 14 records
US 2 records · 2 strengths
GB 2 records · 2 strengths
- 200 mginjectionSivextro 200mg powder for concentrate for solution for infusion vials
- 200 mgtabletSIVEXTRO
SG 2 records · 2 strengths
- 200 mginjectionSIVEXTRO LYOPHILIZED POWDER FOR SOLUTION FOR INFUSION 200MG PER VIAL
- 200 mgtabletSIVEXTRO
ES 2 records · 2 strengths
TW 1 records · 1 strengths
- 200 mginjectionTedizo Lyo Injection 200MG泰帝卓凍晶注射劑200毫克
EU 1 records · 1 strengths
EU centralised authorisation (EMA) — Authorised at EU level — not a record of sale in any single country. The EU register carries no strength, dosage form or pack size.
Records without a stated strength · 1 SIVEXTRO
| Strength / form / release | US | GB | SG | ES | TW | EU |
|---|---|---|---|---|---|---|
| 200 mg injection | Sivextro 200mg powder for concentrate for solution for infusion vials | SIVEXTRO LYOPHILIZED POWDER FOR SOLUTION FOR INFUSION 200MG PER VIAL | SIVEXTRO | Tedizo Lyo Injection 200MG 泰帝卓凍晶注射劑200毫克 | ||
| 200 mg tablet | SIVEXTRO | SIVEXTRO | SIVEXTRO | SIVEXTRO | ||
| 200 mg/4 mL injection | SIVEXTRO | |||||
unknown | SIVEXTRO |
Scroll horizontally for more markets →
Each country column shows the locally registered trade names — not translations.
1 more strength/form rows are recorded only in EU and are not shown in this table. Hay 1 filas de concentración/forma registradas solo en EU que no se muestran en esta tabla. 另有 1 个规格/剂型仅在 EU 有记录（未在本表显示）。 另有 1 個規格/劑型僅在 EU 有記錄（未在本表顯示）。
“not disclosed” means the source does not publish the strength — it does not mean the product has none.
EU centralised authorisation (EMA) — Authorised at EU level — not a record of sale in any single country. The EU register carries no strength, dosage form or pack size.
Discontinued, withdrawn or unverified-status products are hidden by default; Hong Kong and Australia records are shown as exceptions.